Literature DB >> 26432649

Improving the performance of factor VIII inhibitor tests in hemophilia A.

Connie H Miller1.   

Abstract

Entities:  

Keywords:  Factor VIII; Factor VIII inhibitor; Hemophilia

Mesh：

Substances：

Year:  2015        PMID： 26432649      PMCID： PMC4717907          DOI： 10.1016/j.thromres.2015.09.019

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  16 in total

1.  Proceedings: A more uniform measurement of factor VIII inhibitors.

Authors:  C K Kasper; L Aledort; D Aronson; R Counts; J R Edson; J van Eys; J Fratantoni; D Green; J Hampton; M Hilgartner; P Levine; J Lazerson; C McMillan; J Penner; S Shapiro; N R Shulman
Journal:  Thromb Diath Haemorrh       Date:  1975-11-15

2.  Diagnosis and quantification of factor VIII inhibitors.

Authors:  B Verbruggen
Journal:  Haemophilia       Date:  2009-02-18       Impact factor: 4.287

3.  Validation of Nijmegen-Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance.

Authors:  C H Miller; S J Platt; A S Rice; F Kelly; J M Soucie
Journal:  J Thromb Haemost       Date:  2012-06       Impact factor: 5.824

4.  Antibodies to factor VIII. I. Variations in stability of antigen-antibody complexes in hemophilia A.

Authors:  J P Allain; D Frommel
Journal:  Blood       Date:  1973-09       Impact factor: 22.113

5.  The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability.

Authors:  B Verbruggen; I Novakova; H Wessels; J Boezeman; M van den Berg; E Mauser-Bunschoten
Journal:  Thromb Haemost       Date:  1995-02       Impact factor: 5.249

6.  Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom.

Authors:  Charles R M Hay; Ben Palmer; Elizabeth Chalmers; Ri Liesner; Rhona Maclean; Savita Rangarajan; Michael Williams; Peter W Collins
Journal:  Blood       Date:  2011-04-06       Impact factor: 22.113

Review 7.  Laboratory identification of factor inhibitors: the perspective of a large tertiary hemophilia center.

Authors:  Geoffrey Kershaw; Dayani Jayakodi; Scott Dunkley
Journal:  Semin Thromb Hemost       Date:  2010-02-18       Impact factor: 4.180

8.  Use of porcine factor VIII in the management of seventeen patients with factor VIII antibodies.

Authors:  L Gatti; P M Mannucci
Journal:  Thromb Haemost       Date:  1984-07-29       Impact factor: 5.249

9.  Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.

Authors:  Peter W Collins; Elizabeth Chalmers; Daniel P Hart; Ri Liesner; Savita Rangarajan; Kate Talks; Mike Williams; Charles R Hay
Journal:  Br J Haematol       Date:  2012-11-15       Impact factor: 6.998

10.  Heat treatment of samples improve the performance of the Nijmegen-Bethesda assay in hemophilia A patients undergoing immune tolerance induction.

Authors:  Silmara Aparecida de Lima Montalvão; Alini Camargo Tucunduva; Andrea Luísa de Almeida Sambo; Erich Vinicius De Paula; Samuel de Souza Medina; Margareth Castro Ozelo
Journal:  Thromb Res       Date:  2015-08-28       Impact factor: 3.944
View more
  1 in total

Review 1.  European principles of inhibitor management in patients with haemophilia.

Authors:  P L F Giangrande; C Hermans; B O'Mahony; P de Kleijn; M Bedford; A Batorova; J Blatný; K Jansone
Journal:  Orphanet J Rare Dis       Date:  2018-04-27       Impact factor: 4.123
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.